These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 24630239)

  • 1. Effects of the immunosuppressant rapamycin on the expression of human α2(I) collagen and matrix metalloproteinase 1 genes in scleroderma dermal fibroblasts.
    Tamaki Z; Asano Y; Kubo M; Ihn H; Tada Y; Sugaya M; Kadono T; Sato S
    J Dermatol Sci; 2014 Jun; 74(3):251-9. PubMed ID: 24630239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Akt blockade downregulates collagen and upregulates MMP1 in human dermal fibroblasts.
    Bujor AM; Pannu J; Bu S; Smith EA; Muise-Helmericks RC; Trojanowska M
    J Invest Dermatol; 2008 Aug; 128(8):1906-14. PubMed ID: 18323784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2-Methoxyestradiol inhibits bleomycin-induced systemic sclerosis through suppression of fibroblast activation.
    Zhu L; Song Y; Li M
    J Dermatol Sci; 2015 Jan; 77(1):63-70. PubMed ID: 25465161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of granulocyte macrophage-colony stimulating factor on extracellular matrix deposition by dermal fibroblasts from patients with scleroderma.
    Postiglione L; Ladogana P; Montagnani S; di Spigna G; Castaldo C; Turano M; Bruno EM; Di Meglio F; Riccio A; Rossi G
    J Rheumatol; 2005 Apr; 32(4):656-64. PubMed ID: 15801021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of the immunosuppressant FK-506 on human alpha2(I) collagen gene expression and transforming growth factor beta signaling in normal and scleroderma fibroblasts.
    Asano Y; Ihn H; Yamane K; Jinnin M; Mimura Y; Tamaki K
    Arthritis Rheum; 2005 Apr; 52(4):1237-47. PubMed ID: 15818662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ciprofloxacin has antifibrotic effects in scleroderma fibroblasts via downregulation of Dnmt1 and upregulation of Fli1.
    Bujor AM; Haines P; Padilla C; Christmann RB; Junie M; Sampaio-Barros PD; Lafyatis R; Trojanowska M
    Int J Mol Med; 2012 Dec; 30(6):1473-80. PubMed ID: 23041765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Irinotecan and its metabolite SN38 inhibits procollagen I production of dermal fibroblasts from Systemic Sclerosis patients.
    Lapoirie J; Tran L; Piazza L; Contin-Bordes C; Truchetet ME; Bonnet F
    Sci Rep; 2021 Sep; 11(1):18011. PubMed ID: 34504265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CXCL17-mediated downregulation of type I collagen via MMP1 and miR-29 in skin fibroblasts possibly contributes to the fibrosis in systemic sclerosis.
    Shimada S; Makino K; Jinnin M; Sawamura S; Kawano Y; Ide M; Kajihara I; Makino T; Fukushima S; Ihn H
    J Dermatol Sci; 2020 Dec; 100(3):183-191. PubMed ID: 33055012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minocycline does not alter collagen type I metabolism of dermal fibroblasts in culture.
    Anderegg U; Prieb J; Hildebrandt G; Saalbach A
    Arch Dermatol Res; 2002 May; 294(3):103-8. PubMed ID: 12029495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Th17 cells favor inflammatory responses while inhibiting type I collagen deposition by dermal fibroblasts: differential effects in healthy and systemic sclerosis fibroblasts.
    Brembilla NC; Montanari E; Truchetet ME; Raschi E; Meroni P; Chizzolini C
    Arthritis Res Ther; 2013 Oct; 15(5):R151. PubMed ID: 24289089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased accumulation of extracellular thrombospondin-2 due to low degradation activity stimulates type I collagen expression in scleroderma fibroblasts.
    Kajihara I; Jinnin M; Yamane K; Makino T; Honda N; Igata T; Masuguchi S; Fukushima S; Okamoto Y; Hasegawa M; Fujimoto M; Ihn H
    Am J Pathol; 2012 Feb; 180(2):703-14. PubMed ID: 22142808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bosentan reverses the pro-fibrotic phenotype of systemic sclerosis dermal fibroblasts via increasing DNA binding ability of transcription factor Fli1.
    Akamata K; Asano Y; Aozasa N; Noda S; Taniguchi T; Takahashi T; Ichimura Y; Toyama T; Sato S
    Arthritis Res Ther; 2014 Apr; 16(2):R86. PubMed ID: 24708674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basic fibroblast growth factor inhibits basal and transforming growth factor-beta induced collagen alpha 2(I) gene expression in scleroderma and normal fibroblasts.
    Ichiki Y; Smith EA; LeRoy EC; Trojanowska M
    J Rheumatol; 1997 Jan; 24(1):90-5. PubMed ID: 9002017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteasome blockade exerts an antifibrotic activity by coordinately down-regulating type I collagen and tissue inhibitor of metalloproteinase-1 and up-regulating metalloproteinase-1 production in human dermal fibroblasts.
    Fineschi S; Reith W; Guerne PA; Dayer JM; Chizzolini C
    FASEB J; 2006 Mar; 20(3):562-4. PubMed ID: 16410344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment with rapamycin prevents fibrosis in tight-skin and bleomycin-induced mouse models of systemic sclerosis.
    Yoshizaki A; Yanaba K; Yoshizaki A; Iwata Y; Komura K; Ogawa F; Takenaka M; Shimizu K; Asano Y; Hasegawa M; Fujimoto M; Sato S
    Arthritis Rheum; 2010 Aug; 62(8):2476-87. PubMed ID: 20506342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of hepatocyte growth factor on the expression of type I collagen and matrix metalloproteinase-1 in normal and scleroderma dermal fibroblasts.
    Jinnin M; Ihn H; Mimura Y; Asano Y; Yamane K; Tamaki K
    J Invest Dermatol; 2005 Feb; 124(2):324-30. PubMed ID: 15675950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic sclerosis Th2 cells inhibit collagen production by dermal fibroblasts via membrane-associated tumor necrosis factor alpha.
    Chizzolini C; Parel Y; De Luca C; Tyndall A; Akesson A; Scheja A; Dayer JM
    Arthritis Rheum; 2003 Sep; 48(9):2593-604. PubMed ID: 13130479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional regulation of matrix metalloproteinase-1 and collagen 1A2 explains the anti-fibrotic effect exerted by proteasome inhibition in human dermal fibroblasts.
    Goffin L; Seguin-Estévez Q; Alvarez M; Reith W; Chizzolini C
    Arthritis Res Ther; 2010; 12(2):R73. PubMed ID: 20429888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin II in the lesional skin of systemic sclerosis patients contributes to tissue fibrosis via angiotensin II type 1 receptors.
    Kawaguchi Y; Takagi K; Hara M; Fukasawa C; Sugiura T; Nishimagi E; Harigai M; Kamatani N
    Arthritis Rheum; 2004 Jan; 50(1):216-26. PubMed ID: 14730619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imatinib mesylate reduces production of extracellular matrix and prevents development of experimental dermal fibrosis.
    Distler JH; Jüngel A; Huber LC; Schulze-Horsel U; Zwerina J; Gay RE; Michel BA; Hauser T; Schett G; Gay S; Distler O
    Arthritis Rheum; 2007 Jan; 56(1):311-22. PubMed ID: 17195235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.